One of the advanced treatments we provide is semaglutide, a medication originally developed to treat type 2 diabetes
Weekly semaglutide injections induce and prolong the effects of elevated GLP-1, such as: Reduced Insulin Resistance High Metabolism the ability to burn calories Slower Gastric Emptying Process food transport from the stomach to small intestines (prolongs the feeling of fullness ) Increased Satiety smaller portion sizes satisfy hunger Smaller Appetite decreased desire to eat How does Zepbound work
Check Your Eligibility If you want personalized guidance on GLP-1 dosing, titration timing, and side effect management, you can start by completing Mochi's eligibility questionnaire
Food and Drug Administration approved semaglutide, under the brand name Wegovy, for chronic weight management in obese and overweight adults
Because of this, dramatic changes in the first seven days are uncommon and not necessarily an indicator of longterm success